The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Specificity and mechanism of action of some commonly used protein kinase inhibitors
Abstract
The specificities of 28 commercially available compounds reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases have been examined against a large panel of protein kinases. The compounds KT 5720, Rottlerin and quercetin were found to inhibit many protein kinases, sometimes much more potently than their presumed targets, and conclusions drawn from their use in cell-based experiments are likely to be erroneous. Ro 318220 and related bisindoylmaleimides, as well as H89, HA1077 and Y 27632, were more selective inhibitors, but still inhibited two or more protein kinases with similar potency. LY 294002 was found to inhibit casein kinase-2 with similar potency to phosphoinositide (phosphatidylinositol) 3-kinase. The compounds with the most impressive selectivity profiles were KN62, PD 98059, U0126, PD 184352, rapamycin, wortmannin, SB 203580 and SB 202190. U0126 and PD 184352, like PD 98059, were found to block the mitogen-activated protein kinase (MAPK) cascade in cell-based assays by preventing the activation of MAPK kinase (MKK1), and not by inhibiting MKK1 activity directly. Apart from rapamycin and PD 184352, even the most selective inhibitors affected at least one additional protein kinase. Our results demonstrate that the specificities of protein kinase inhibitors cannot be assessed simply by studying their effect on kinases that are closely related in primary structure. We propose guidelines for the use of protein kinase inhibitors in cell-based assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A well-known PKA inhibitor is H89, an isoquinoline high-affinity ATP-competitive inhibitor widely used in cells to block PKA-mediated signaling despite its documented off-target effects (18).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
Self-citationTOR signalling and control of cell growth
Thomas, G., & Hall, M. N. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80078-6 · Cited by 462 · cited 1×
“They include rapamycin, an inhibitor of the protein kinase mTOR (mammalian target of rapamycin, also called FRAP) [ 2 ], an immunosuppressant that has recently been approved for clinical”
Background
Cited by
Items 201–297 of 297
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Workman, P., Clarke, P. A., Raynaud, F. I., & van Montfort, R. L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4355 · Cited by 264
Hurley, R. L., Barré, L. K., Wood, S. D., Anderson, K. A., Kemp, B. E., Means, A. R., & Witters, L. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606676200 · Cited by 263
Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., & Iwatsubo, T. (2007) · Biochemistry · doi:10.1021/bi061960m · Cited by 263
Targeting Glycosylation: A New Road for Cancer Drug Discovery
Costa, A. F., Campos, D., Reis, C. A., & Gomes, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.04.002 · Cited by 263
Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53
Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305870200 · Cited by 262
Rho-kinase as a Novel Therapeutic Target in Treatment of Cardiovascular Diseases
Shimokawa, H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200203000-00001 · Cited by 262
Nolan, M. A., Babcock, D. F., Wennemuth, G., Brown, W., Burton, K. A., & McKnight, G. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405580101 · Cited by 259
Chiari, P. C., Bienengraeber, M. W., Pagel, P. S., Krolikowski, J. G., Kersten, J. R., & Warltier, D. C. (2005) · Anesthesiology · doi:10.1097/00000542-200501000-00018 · Cited by 258
Mohri, M., Shimokawa, H., Hirakawa, Y., Masumoto, A., & Takeshita, A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02632-3 · Cited by 257
CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Prkcz null mice show normal learning and memory
Lee, A. M., Kanter, B. R., Wang, D., Lim, J. P., Zou, M. E., Qiu, C., McMahon, T., Dadgar, J., Fischbach-Weiss, S. C., & Messing, R. O. (2013) · Nature · doi:10.1038/nature11803 · Cited by 257
Protein kinase inhibitors: contributions from structure to clinical compounds
Johnson, L. N. (2009) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583508004745 · Cited by 256
Song, L., De Sarno, P., & Jope, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206047200 · Cited by 256
Knebel, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4360 · Cited by 254
Kotliarova, S., Pastorino, S., Kovell, L. C., Kotliarov, Y., Song, H., Zhang, W., Bailey, R., Maric, D., Zenklusen, J. C., Lee, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0850 · Cited by 254
Dumaz, N., & Marais, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300182200 · Cited by 252
Cahill, C. M., & Rogers, J. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707692200 · Cited by 252
Buteau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252
Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239
Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25
Nagy, G., Reim, K., Matti, U., Brose, N., Binz, T., Rettig, J., Neher, E., & Sørensen, J. B. (2004) · Neuron · doi:10.1016/s0896-6273(04)00038-8 · Cited by 239
ROCK inhibition in models of neurodegeneration and its potential for clinical translation
Koch, J. C., Tatenhorst, L., Roser, A.-E., Saal, K.-A., Tönges, L., & Lingor, P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.008 · Cited by 239
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck
Amornphimoltham, P., Patel, V., Sodhi, A., Nikitakis, N. G., Sauk, J. J., Sausville, E. A., Molinolo, A. A., & Gutkind, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0921 · Cited by 238
Knipe, R. S., Tager, A. M., & Liao, J. K. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009381 · Cited by 233
Chibalin, A. V., Leng, Y., Vieira, E., Krook, A., Björnholm, M., Long, Y. C., Kotova, O., Zhong, Z., Sakane, F., Steiler, T., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.035 · Cited by 232
The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., et al. (2007) · Diabetes · doi:10.2337/db06-1016 · Cited by 230
Wijesekara, N., Krishnamurthy, M., Bhattacharjee, A., Suhail, A., Sweeney, G., & Wheeler, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085084 · Cited by 229
A Role for Prefrontal Cortex in Memory Storage for Trace Fear Conditioning
Runyan, J. D., Moore, A. N., & Dash, P. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4880-03.2004 · Cited by 224
Vicent, G. P., Ballaré, C., Nacht, A. S., Clausell, J., Subtil-Rodríguez, A., Quiles, I., Jordan, A., & Beato, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.011 · Cited by 223
“However, H89 also inhibits protein kinase A (Davies et al., 2000).”
BackgroundLochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
Lingor, P., Teusch, N., Schwarz, K., Mueller, R., Mack, H., Bähr, M., & Mueller, B. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04756.x · Cited by 214
“…have coinhibitory activities by potentially blocking related kinases, such as protein kinase N, protein kinase A (PKA), protein kinase C, mitogen- and stress-activated protein kinase 1, citron kinase or myosin light chain kinase, which may be relevant for neurite outgrowth (Davies et al. 2000).”
BackgroundInfluentialChapter 6 Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase
Abel, T., & Nguyen, P. V. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(07)00006-4 · Cited by 198
ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
Koch, J. C., Tönges, L., Barski, E., Michel, U., Bähr, M., & Lingor, P. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.191 · Cited by 197
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
Jimenez-Vargas, N. N., Pattison, L. A., Zhao, P., Lieu, T., Latorre, R., Jensen, D. D., Castro, J., Aurelio, L., Le, G. T., Flynn, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721891115 · Cited by 185
Coffey, E. T., Smiciene, G., Hongisto, V., Cao, J., Brecht, S., Herdegen, T., & Courtney, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04335.2002 · Cited by 184
“The isoform is equally sensitive, and / are insensitive (Stein et al., 1997; Davies et al., 2000).”
BackgroundInfluentialTonges, L., Frank, T., Tatenhorst, L., Saal, K. A., Koch, J. C., Szego, E. M., Bahr, M., Weishaupt, J. H., & Lingor, P. (2012) · Brain · doi:10.1093/brain/aws254 · Cited by 176
Rho-kinase: Regulation, (dys)function, and inhibition
Amin, E., Dubey, B. N., Zhang, S.-C., Gremer, L., Dvorsky, R., Moll, J. M., Taha, M. S., Nagel-Steger, L., Piekorz, R. P., Somlyo, A. V., et al. (2013) · bchm · doi:10.1515/hsz-2013-0181 · Cited by 176
Guardiola‐Diaz, H. M., Ishii, A., & Bansal, R. (2012) · Glia · doi:10.1002/glia.22281 · Cited by 171
Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection
Kong, Q., Chang, L.-C., Takahashi, K., Liu, Q., Schulte, D. A., Lai, L., Ibabao, B., Lin, Y., Stouffer, N., Mukhopadhyay, C. D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66163 · Cited by 156
Verhaegen, M., Bauer, J. A., Martín de la Vega, C., Wang, G., Wolter, K. G., Brenner, J. C., Nikolovska-Coleska, Z., Bengtson, A., Nair, R., Elder, J. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1748 · Cited by 140
Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M., & Cuenda, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01655 · Cited by 133
“SB203580 is a relatively specific inhibitor of p38α and p38β activity, whereas PD184352 is a potent inhibitor of the ERK1/2 and ERK5 pathways (Davies et al., 2000; Mody et al., 2003).”
BackgroundHisaoka, K., Nishida, A., Koda, T., Miyata, M., Zensho, H., Morinobu, S., Ohta, M., & Yamawaki, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00531.x · Cited by 133
Krämer, D. K., Al-Khalili, L., Perrini, S., Skogsberg, J., Wretenberg, P., Kannisto, K., Wallberg-Henriksson, H., Ehrenborg, E., Zierath, J. R., & Krook, A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1157 · Cited by 132
“SB203580 has been reported to have a small inhibitory effect on PKB/Akt activity (31).”
BackgroundChan, M. H. S., McGee, S. L., Watt, M. J., Hargreaves, M., & Febbraio, M. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-1039fje · Cited by 127
“MAPK, since this compound has been shown to prevent p38 phosphorylation and no other protein kinase at the concentration used in this experiment (31).”
MethodTönges, L., Günther, R., Suhr, M., Jansen, J., Balck, A., Saal, K., Barski, E., Nientied, T., Götz, A. A., Koch, J., et al. (2014) · Glia · doi:10.1002/glia.22601 · Cited by 121
“Similar to earlier studies, we observed an attenuation of protective effects at higher Fasudil concentrations, which has been attributed to off-target inhibition of other kinases such as PKN1 and PKC (Davies et al., 2000; Lingor et al., 2007).”
ResultTalior, I., Tennenbaum, T., Kuroki, T., & Eldar-Finkelman, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2004 · Cited by 120
Liu, R., & Proud, C. G. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.123 · Cited by 117
mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse
Neasta, J., Barak, S., Hamida, S. B., & Ron, D. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12725 · Cited by 114
Henriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2002 · Cited by 108
Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway
Probin, V., Wang, Y., & Zhou, D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.020 · Cited by 105
“To further clarify the roles of the p53 pathway and the Erk-p38 MAPK cascade in BU-induced senescence, WI38 cells were pre-treated with α-PFT, PD98059, SB203580, and SP600125 prior to BU treatment to specifically inhibit p53, Erk, p38, and JNK, respectively [21,22].”
MethodLeroy, K., Ando, K., Héraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J.-P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1276 · Cited by 103
“It should be pointed that lithium is not a specific inhibitor of GSK-3β and also inhibits other protein kinases [50,51], which might have play a role in the observed reduction of tau phosphorylation.”
Regulation of mitochondria distribution by RhoA and formins
Minin, A. A., Kulik, A. V., Gyoeva, F. K., Li, Y., Goshima, G., & Gelfand, V. I. (2006) · Journal of Cell Science · doi:10.1242/jcs.02762 · Cited by 102
Berkeley, J. L., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., & Levey, A. I. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1042 · Cited by 98
Regulation of tyrosine hydroxylase by stress-activated protein kinases
Toska, K., Kleppe, R., Armstrong, C. G., Morrice, N. A., Cohen, P., & Haavik, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01172.x · Cited by 95
Self-citationZhang, L., Valdez, J. M., Zhang, B., Wei, L., Chang, J., & Xin, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018271 · Cited by 95
Saberi, B., Ybanez, M. D., Johnson, H. S., Gaarde, W. A., Han, D., & Kaplowitz, N. (2014) · Hepatology · doi:10.1002/hep.26625 · Cited by 88
Iron control of erythroid development by a novel aconitase-associated regulatory pathway
Bullock, G. C., Delehanty, L. L., Talbot, A.-L., Gonias, S. L., Tong, W.-H., Rouault, T. A., Dewar, B., Macdonald, J. M., Chruma, J. J., & Goldfarb, A. N. (2010) · Blood · doi:10.1182/blood-2009-10-251496 · Cited by 85
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes
González, N., Acitores, A., Sancho, V., Valverde, I., & Villanueva-Peñacarrillo, M. L. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.002 · Cited by 85
Bonney, S., Seitz, S., Ryan, C. A., Jones, K. L., Clarke, P., Tyler, K. L., & Siegenthaler, J. A. (2019) · mBio · doi:10.1128/mbio.01675-19 · Cited by 79
Kaihara, K. A., Dickson, L. M., Jacobson, D. A., Tamarina, N., Roe, M. W., Philipson, L. H., & Wicksteed, B. (2013) · Diabetes · doi:10.2337/db12-1013 · Cited by 80
“The PKA inhibitors H89 and KT5720 inhibit a number of other kinases with similar or greater efficacy than PKA (37).”
BackgroundcAMP-Dependent Axon Guidance Is Distinctly Regulated by Epac and Protein Kinase A
Murray, A. J., Tucker, S. J., & Shewan, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3071-09.2009 · Cited by 80
Kinugawa, K., Jeong, M. Y., Bristow, M. R., & Long, C. S. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0503 · Cited by 80
Sancho, V., Trigo, M. V., González, N., Valverde, I., Malaisse, W. J., & Villanueva-Peñacarrillo, M. L. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01747 · Cited by 78
Rho-kinase ROCK inhibitors reduce oligomeric tau protein
Hamano, T., Shirafuji, N., Yen, S.-H., Yoshida, H., Kanaan, N. M., Hayashi, K., Ikawa, M., Yamamura, O., Fujita, Y., Kuriyama, M., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.009 · Cited by 76
Nemo-like kinase, a multifaceted cell signaling regulator
Ishitani, T., & Ishitani, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.017 · Cited by 71
Lee, Y. J., & Shukla, S. D. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.006 · Cited by 70
Akt acutely activates the cholesterogenic transcription factor SREBP-2
Luu, W., Sharpe, L. J., Stevenson, J., & Brown, A. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.09.017 · Cited by 68
Crosstalk between TGF-β and MAPK Signaling during Corneal Wound Healing
Terai, K., Call, M. K., Liu, H., Saika, S., Liu, C.-Y., Hayashi, Y., Chikama, T.-I., Zhang, J., Terai, N., Kao, C. W.-C., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8017 · Cited by 64
Wang, W., Nepiyushchikh, Z., Zawieja, D. C., Chakraborty, S., Zawieja, S. D., Gashev, A. A., Davis, M. J., & Muthuchamy, M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2009 · Cited by 64
“SP induces contraction through the Ca(2) -CaM-MLCK pathway in different muscle types, including lymphatics (6, 10).”
BackgroundYu, C. F., Roshan, B., Liu, Z.-X., & Cantley, L. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104493200 · Cited by 63
Large-scale cytological profiling for functional analysis of bioactive compounds
Woehrmann, M. H., Bray, W. M., Durbin, J. K., Nisam, S. C., Michael, A. K., Glassey, E., Stuart, J. M., & Lokey, R. S. (2013) · Molecular BioSystems · doi:10.1039/c3mb70245f · Cited by 62
Gopalakrishnan, S. M., Teusch, N., Imhof, C., Bakker, M. H. M., Schurdak, M., Burns, D. J., & Warrior, U. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21671 · Cited by 62
“In addition to its more specific response on ROCK, these three compounds were capable of blocking other related kinases such as protein kinase A, protein kinase C, citron kinase, or myosin light chain kinase, which are known to have effects on neurite outgrowth (Davies et al., 2000; Ikenoya et al., 2002).”
BackgroundRapid activation of ERK by 6‐hydroxydopamine promotes survival of dopaminergic cells
Lin, E., Cavanaugh, J. E., Leak, R. K., Perez, R. G., & Zigmond, M. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21478 · Cited by 62
Smolen, P., Baxter, D. A., & Byrne, J. H. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.072470 · Cited by 61
Whittard, J. D., Sakurai, T., Cassella, M. R., Gazdoiu, M., & Felsenfeld, D. P. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0090 · Cited by 59
Akinaga, J., Lima, V., Kiguti, L. R. D. A., Hebeler-Barbosa, F., Alcántara-Hernández, R., García-Sáinz, J. A., & Pupo, A. S. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082313 · Cited by 58
Nusser, N., Gosmanova, E., Makarova, N., Fujiwara, Y., Yang, L., Guo, F., Luo, Y., Zheng, Y., & Tigyi, G. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.010 · Cited by 57
Yap, J. J., Chartoff, E. H., Holly, E. N., Potter, D. N., Carlezon, W. A., & Miczek, K. A. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3796-7 · Cited by 55
“We believe this effect to be due to U0126-mediated inhibition of ERK, based on this drug’s potency and selectivity for MKK1 (Davies et al. 2000) and based on our finding that intra-VTA U0126 reduced pERK expression after a single defeat stress.”
InfluentialKarakas, D., & Ozpolat, B. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01917-8 · Cited by 54
Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
Guiler, W., Koehler, A., Boykin, C., & Lu, Q. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661612 · Cited by 51
Lau, C. L., Perreau, V. M., Chen, M. J., Cate, H. S., Merlo, D., Cheung, N. S., O'Shea, R. D., & Beart, P. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22838 · Cited by 49
“Overall, apart from CXCL12, the expression profiles of the genes investigated by qRT-PCR showed a high degree of concordance confirming the two ROCK inhibitors have similar biological actions, despite some differences in their kinase specificity (Davies et al., 2000).”
ResultStatins revert doxorubicin resistance via nitric oxide in malignant mesothelioma
Riganti, C., Orecchia, S., Pescarmona, G., Betta, P. G., Ghigo, D., & Bosia, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21832 · Cited by 48
Dual Roles for RHOA/RHO-Kinase In the Regulated Trafficking of a Voltage-sensitive Potassium Channel
Stirling, L., Williams, M. R., & Morielli, A. D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1074 · Cited by 45
Nemo‐like kinase is involved in NGF‐induced neurite outgrowth via phosphorylating MAP1B and paxillin
Ishitani, T., Ishitani, S., Matsumoto, K., & Itoh, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06400.x · Cited by 46
Aggarwal, C., Łabuz, J., & Gabryś, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055393 · Cited by 40
Regulation of pendrin by cAMP: possible involvement in β-adrenergic-dependent NaCl retention
Azroyan, A., Morla, L., Crambert, G., Laghmani, K., Ramakrishnan, S., Edwards, A., & Doucet, A. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00403.2011 · Cited by 34
Kwan, E. P., Gao, X., Leung, Y. M., & Gaisano, H. Y. (2007) · Pancreas · doi:10.1097/mpa.0b013e318073d1c9 · Cited by 33
STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma
Ouédraogo, Z. G., Müller‐Barthélémy, M., Kemeny, J., Dedieu, V., Biau, J., Khalil, T., Raoelfils, L. I., Granzotto, A., Pereira, B., Beaudoin, C., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12254 · Cited by 33
McCoy, P., Norton, T. T., & McMahon, L. L. (2008) · Journal of Neurophysiology · doi:10.1152/jn.01134.2007 · Cited by 30
Takemoto, K., Ishihara, S., Mizutani, T., Kawabata, K., & Haga, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117937 · Cited by 30
Yang, P., Zhao, Y., Zhao, L., Yuan, J., Chen, Y., Varghese, Z., Moorhead, J. F., Chen, Y., & Ruan, X. Z. (2015) · Scientific Reports · doi:10.1038/srep14959 · Cited by 21
Dadehbeigi, N., & Dickson, A. J. (2015) · Biotechnology Journal · doi:10.1002/biot.201500075 · Cited by 16
Weng, W., Chen, Y., Wang, M., Zhuang, Y., & Behnisch, T. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00247 · Cited by 14
ERK signaling is required for eye-specific retino-geniculate segregation
Naska, S., Cenni, M. C., Menna, E., & Maffei, L. (2004) · Development · doi:10.1242/dev.01212 · Cited by 14
Liu, L., Song, W., Zeng, J., & Peng, Z. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00149 · Cited by 8
Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders
Tridente, G., Jana, A., Nath, A., & Ashraf, G. M. (2023) · Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders · doi:10.1016/b978-0-443-18677-6.00015-4 · Cited by 8
Bruystens, J. G. H., Wu, J., Tan, G., Bertinetti, D., Zenn, H.-M., Zimmermann, B., Chen, L., Köckenberger, J., Massaro, F., Sankaran, B., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536312123 · Cited by 3
Metadata
- Authors
- DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-09-26
- Volume
- 351
- Issue
- 1
- Pages
- 95-105
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W4247904703
- Cited by
- 3,132
- References
- 3
- FWCI
- 49.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.